logo
4-year-old Ohio girl in coma after serious flu complications

4-year-old Ohio girl in coma after serious flu complications

Yahoo01-03-2025

A 4-year-old girl from Ohio is in a coma after suffering complications from the flu, according to our media partners WBNS-10 TV.
[DOWNLOAD: Free WHIO-TV News app for alerts as news breaks]
Locklynn Boler, of Chillicothe, tested positive for the flu on Feb. 21.
TRENDING STORIES:
President Donald Trump to issue posthumous pardon for Pete Rose
Wanted man arrested at local grocery store
Man convicted of setting father's fiancée on fire, killing her avoids death penalty
Three days later she collapsed while trying to go to the bathroom.
'They had to do three rounds of CPR to bring her back, put a vent in then they had to call Life Flight to bring her to Children's,' said Locklynn's mother, Haley Dyke told WBNS-10 TV.
Locklynn suffered brain damage after going into cardiac arrest and losing oxygen to her brain.
Her family describes her as vibrant and healthy, but now will never be able to walk, talk or eat on her own again.
'You always hear things like this happening to other families. You don't ever expect it to happen to your own family and when something like this happens, it really hits and makes you think twice about everything,' Locklynn's aunt, Bethany Patrick, told WBNS-10.
Locklynn's family said it's important to make every moment count.
'Take other people's health seriously, not just your own,' Patrick said.
[SIGN UP: WHIO-TV Daily Headlines Newsletter]

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Kettering Health Cyberattack: Here's what is being done for patients with sensitive info on dark web
Kettering Health Cyberattack: Here's what is being done for patients with sensitive info on dark web

Yahoo

time7 hours ago

  • Yahoo

Kettering Health Cyberattack: Here's what is being done for patients with sensitive info on dark web

Kettering Health has announced that they have resumed normal operations after key services were knocked out by a cyberattack for nearly three weeks. [DOWNLOAD: Free WHIO-TV News app for alerts as news breaks] They say they are working to identify what data was impacted in the cyberattack. 'Our investigation is ongoing, and we will directly notify any impacted individuals,' Kettering Health said in their press release. 'Notifications may include fraud protection resources, such as identity theft or credit monitoring.' >>RELATED: Kettering Health officials acknowledge impacts of cyber attack are 'extremely frustrating' TRENDING STORIES: New evidence raises more questions in search for father accused of killing 3 daughters Brand new aviation video shows man throwing wood at deputies, causing wrong-way crash on I-75 'Long and difficult process,' Pastor speaks on restoration efforts after fire at Catholic church Kettering Health says services such as surgery, imaging, retail pharmacy and physician office visits are back to normal. MyChart, which was restored Monday, is functional for patients. According to an update from the network, patients are now able to view upcoming appointments, schedule appointments, view prescription lists, message their providers and view test results. >>PREVIOUS COVERAGE: Kettering Health cyberattack; Hacker group claims responsibility, sensitive info put on dark web Kettering Health says their cyber security and employee security training will 'effectively mitigate future risks.' News Center 7 will continue to follow this story. [SIGN UP: WHIO-TV Daily Headlines Newsletter]

UGA insect expert says Asian needle ants could be a hidden danger for some
UGA insect expert says Asian needle ants could be a hidden danger for some

Yahoo

time7 hours ago

  • Yahoo

UGA insect expert says Asian needle ants could be a hidden danger for some

If you've ever had a bad reaction to a bee sting or a wasp sting, there's another threat to watch out for this summer. Channel 2's Lori Wilson spoke to the University of Georgia's leading insect expert about the Asian needle ant and its powerful sting. 'If you suffer from anaphylaxis, you know it. You carry an Epipen around. You probably should know what this ant looks like,' University of Georgia entomologist Dan Suiter said. [DOWNLOAD: Free WSB-TV News app for alerts as news breaks] 'For a long time, it's flown under the radar. It's just, I tell folks, it's cryptic. It's kind of a hidden ant. It's an ant. Nobody pays attention to ants,' he said. But at 1/16th of an inch long and shiny black, this ant is one to watch for. Suiter said the stinger can pierce through clothing and has venom that can trigger anaphylaxis, a life-threatening reaction that can cause swelling of the tongue and throat and difficulty breathing. PREVIOUS COVERAGE: Asian needle ants crawling across US, now found in 20 states, sting cause life-threatening reaction 'I'm confident that people wind up in the emergency room in distress. They're rescued by the physician for anaphylaxis and never know what happened,' Suiter said. He said they live in small colonies, leaf litter, in dead logs and things of that nature. 'And you'll see them kind of foraging around by themselves. That is odd for an ant. And so anything you pick up off the ground, turn it over before you carry it and look to see, make sure there's not these little black ants crawling around underneath it,' Suiter said. TRENDING STORIES: Raids uncover largest fentanyl pill operation in state history in Atlanta, Douglasville Man charged with posing as nurse, dispensing morphine at Haralson nursing home 'Black Mecca' no longer? Atlanta prices cause families to move out of the city [SIGN UP: WSB-TV Daily Headlines Newsletter]

Parents are dismayed after FDA rejects experimental drug 4-year-old girl relies on
Parents are dismayed after FDA rejects experimental drug 4-year-old girl relies on

Yahoo

time7 hours ago

  • Yahoo

Parents are dismayed after FDA rejects experimental drug 4-year-old girl relies on

A family thought they had a life-changing drug for their 4-year-old daughter. Then the FDA rejected it. Channel 2's Michael Doudna heard from the girl's parents. For Hope Filchak, her daily routine includes a daily shot to help provide a normal life. However, soon the drug may go away. 'It's scary to think she might not have this in just a few months,' Caroline Filchak, Hope's mother, said. [DOWNLOAD: Free WSB-TV News app for alerts as news breaks] Hope was born with a rare mitochondrial disease that impacts fewer than 100 people in the world. The impacts are wide-ranging and a challenge to overcome. 'From early on, it was an uphill battle for Hope,' Caroline Filchak said. 'I think she's got 12 specialists that we see in three different states.' 'It affects her brain, her heart, her eyes and her ears, deafness, blindness, and then two heart defects,' Ben Filchak, Hope's father, said. There are no FDA-approved drugs for Hope's condition. So when heart troubles arose in 2024, the family was forced to turn to an experimental drug, elemipretide, and saw immediate improvement. 'Her energy increased, and her heart function has stabilized completely,' Ben Fiilchak said. However, last month, the FDA declined to give it approval. 'I would say that the FDA is trying to regulate two things, right. They're trying to make sure the products are safe, including drugs, but also that they are efficacious for people,' said Rossana Sanchez Russo, an Emory clinical geneticist. According to the parent company producing the drug, the FDA's rejection was in part because the FDA did not see an improvement in a six-minute walk test. 'We all know in the field that a six-minute walk test is not the be-all end-all outcome measure for mitochondrial diseases,' Amy Goldstein, a leading mitochondrial disease expert, said. She says the drug showed improvement in areas such as quality of life and cardiac health. 'I myself personally saved a baby in my cardiac ICU with Barre syndrome. He went home with no cardiac manifestations after arriving here in severe heart failure and needing a heart transplant,' Goldstein said. 'We were extremely disappointed that based on all of the data, they made the decision not to approve the drug.' Another hurdle rare disease drug testing faces is sample size. By its very nature, only a few people have these diseases, so getting a meaningful sample during clinical trials can be difficult. 'Sometimes we don't have enough burden of proof to be able to formally say that. That doesn't mean that it may not be working for a family or that it might not work for other conditions. It may mean that we just do not have all the data,' Sanchez Russo said. The FDA says the company behind the drug can reapply for approval, but it is unclear if it will be successful and how long the company can stay committed to producing a drug without the FDA giving an OK. Hope's family has a four-month supply of the drug left. However, they do not know how much longer access to the medicine will last. 'Hope is a special little girl, and she means so much to our family,' Caroline Filchak said. TRENDING STORIES: Raids uncover largest fentanyl pill operation in state history in Atlanta, Douglasville Hurricane season starts quietly in the Atlantic They were once best friends, then one killed the other. We take you inside this bizarre murder case [SIGN UP: WSB-TV Daily Headlines Newsletter]

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store